Role of metabolic endotoxemia in systemic inflammation and potential interventions
S Mohammad, C Thiemermann - Frontiers in immunology, 2021 - frontiersin.org
Diet-induced metabolic endotoxemia is an important factor in the development of many
chronic diseases in animals and man. The gut epithelium is an efficient barrier that prevents …
chronic diseases in animals and man. The gut epithelium is an efficient barrier that prevents …
Regulation of gut microbiota and metabolic endotoxemia with dietary factors
N Fuke, N Nagata, H Suganuma, T Ota - Nutrients, 2019 - mdpi.com
Metabolic endotoxemia is a condition in which blood lipopolysaccharide (LPS) levels are
elevated, regardless of the presence of obvious infection. It has been suggested to lead to …
elevated, regardless of the presence of obvious infection. It has been suggested to lead to …
Metabolic endotoxaemia: is it more than just a gut feeling?
MK Piya, AL Harte, PG McTernan - Current opinion in lipidology, 2013 - journals.lww.com
Gut flora appears to act as an important determinant in the pathogenesis of inflammatory
induced obesity/T2DM. Endotoxin may act as the systemic insult, impacted by a high-fat diet …
induced obesity/T2DM. Endotoxin may act as the systemic insult, impacted by a high-fat diet …
A high-fat diet is associated with endotoxemia that originates from the gut
S Pendyala, JM Walker, PR Holt - Gastroenterology, 2012 - Elsevier
Endotoxemia, characterized by an excess of circulating bacterial wall lipopolysaccharide, is
associated with systemic inflammation and the metabolic syndrome. Placing 8 healthy …
associated with systemic inflammation and the metabolic syndrome. Placing 8 healthy …
Of microbes and meals: the health consequences of dietary endotoxemia
The human intestinal tract comprises a rich and complex microbial ecosystem. This intestinal
microbota provides a large reservoir of potentially toxic molecules, including bacterial …
microbota provides a large reservoir of potentially toxic molecules, including bacterial …
Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation
F Laugerette, C Vors, N Peretti, MC Michalski - Biochimie, 2011 - Elsevier
Metabolic diseases such as obesity are characterized by a subclinical inflammatory state
that contributes to the development of insulin resistance and atherosclerosis. Recent reports …
that contributes to the development of insulin resistance and atherosclerosis. Recent reports …
[PDF][PDF] Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk
AL Neves, J Coelho, L Couto, A Leite-Moreira… - J Mol …, 2013 - scholar.archive.org
Obesity is associated with significantly increased cardiovascular (CV) risk and mortality.
Several molecular mechanisms underlying this association have been implied, among …
Several molecular mechanisms underlying this association have been implied, among …
Metabolic endotoxemia is dictated by the type of lipopolysaccharide
FF Anhê, NG Barra, JF Cavallari, BD Henriksbo… - Cell Reports, 2021 - cell.com
Lipopolysaccharides (LPSs) can promote metabolic endotoxemia, which is considered
inflammatory and metabolically detrimental based on Toll-like receptor (TLR) 4 agonists …
inflammatory and metabolically detrimental based on Toll-like receptor (TLR) 4 agonists …
Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics
J Moludi, V Maleki, H Jafari‐Vayghyan… - Clinical and …, 2020 - Wiley Online Library
Translocation of microbiome‐derived lipopolysaccharide (LPS) to the bloodstream
(metabolic endotoxaemia) is associated with a significantly increased risk of cardiovascular …
(metabolic endotoxaemia) is associated with a significantly increased risk of cardiovascular …
Metabolic endotoxemia initiates obesity and insulin resistance
Diabetes and obesity are two metabolic diseases characterized by insulin resistance and a
low-grade inflammation. Seeking an inflammatory factor causative of the onset of insulin …
low-grade inflammation. Seeking an inflammatory factor causative of the onset of insulin …